Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

CompletedOBSERVATIONAL
Enrollment

241

Participants

Timeline

Start Date

October 23, 2007

Primary Completion Date

May 20, 2010

Study Completion Date

July 7, 2012

Conditions
Breast Carcinoma Metastatic to the Bone
Interventions
DIAGNOSTIC_TEST

BOMET-QoL questionnaire

study to evaluate the utility of the BOMET-QoL questionnaire in patients with BC and BM

Trial Locations (15)

15006

Complejo Hospitalario Universitario A Coruña, A Coruña

15009

Centro Oncologico de Galicia, A Coruña

17007

ICO Girona Hospital Dr. Josep Trueta, Girona

19002

Hospital General de Guadalajara, Guadalajara

22300

Hospital de Barbastro, Barbastro

25198

Hospital Universitari Arnau de Vilanova, Lleida

36164

Complejo Hospitalario de Pontevedra, Pontevedra

41013

Hospital Universitario Virgen Del Rocío, Seville

46010

Hospital Clínico Universitario de Valencia, Valencia

08916

ICO Badalona Hospital Universitari Germans Trias I Pujol, Badalona

08036

Hospital Universitari Clinic I Provincial, Barcelona

08041

Hospital Santa Creu I Sant Pau, Barcelona

08221

Hospital Mutua de Terrassa, Barcelona

08243

Fundació Althaia, Xarxa Assistencial de Manresa, Manresa

03010

Hospital General Universitario de Alicante, Alicante

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER